Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on July 30, 2008
J Am Soc Nephrol 19: 1855-1864, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2008010092
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2008010092v1
19/10/1855    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Rodriguez-Iturbe, B.
Right arrow Articles by Musser, J. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez-Iturbe, B.
Right arrow Articles by Musser, J. M.

Special Article

The Current State of Poststreptococcal Glomerulonephritis

Bernardo Rodriguez-Iturbe* and James M. Musser{dagger}

* Renal Department, Hospital Universitario, Universidad del Zulia and Centro de Investigaciones Biomédicas, IVIC-Zulia, Maracaibo, Venezuela; and {dagger} Center for Molecular and Translational Human Infectious Diseases Research and Department of Pathology, Methodist Hospital Research Institute, Houston, Texas

Correspondence: Dr. Bernardo Rodriguez-Iturbe, Renal Service Hospital Universitario de Maracaibo, Avenue Goajira s/n, Estado Zulia, Maracaibo, Venezuela. Phone: +58-261-7519610; Fax: +58-261-7524838; E-mail: bernardori{at}movistar.net.ve

Poststreptococcal glomerulonephritis is one of the oldest recognized renal diseases. In the past three decades, significant changes have occurred in its epidemiology, in new insight gained in the nephritogenic characteristics of streptococcal antigens, and in the natural history of the disease. The disease is now rare in industrialized nations, but in the underprivileged world, the burden of poststreptococcal glomerulonephritis ranges between 9.5 and 28.5 new cases per 100,000 individuals per year. Prophylactic antibiotic treatment is advisable in epidemic conditions and to household contacts of index cases in communities where the prevalence of the disease is high. The long-term prognosis is variable; in general, prognosis is excellent in children but significantly worse when it occurs in elderly individuals and in populations that present other risk factors of chronic kidney disease. Contemporary large-scale research strategies such as genome-wide sequencing may uncover new information about pathogenic factors contributing to disease.






HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673